Our goals and ambitions
Coordinated by the University of Bologna, the new European project will develop portable devices with a level of sensitivity equal or higher than that of molecular PCR swabs, and with much faster results. Eclipse aims to design and produce a nanobiotechnological platform for the detection of pathogens that is both economical, usable even by non-expert personnel and with a high level of sensitivity and reliability.
The ultimate detection
Finding novel tools for pathogen detection for a new platform that will exploit innovative ultrasensitive protocols.
A platform for everybody
Making the detection reliable, fast, cheap, portable and simple to use even by a non-expert.

Against the next virus
Applying the platform to many other infectious agents, making it a "ready for the next pandemic” technology.
How we will work
Demonstrating the feasibility and adaptability of the ECLIPSE platform with three test cases: a virus, a bacterium and a protozoan.
16 January 2023
ECLipse Brochure is now online
Download our brochure to know more about ECLIPSE goals, our technology and all the research teams…
8 June 2022
Advanced photodynamic therapy with an engineered M13 phage targeting EGFR
Photodynamic therapy (PDT) is a potential synergistic approach to chemotherapy for treating ovarian…
8 June 2022
Publication by Sabrina Conoci, Luca Prodi and Giovanni Valenti on Biosensors and Bioelectronics
P. Nikolaou, E. L. Sciuto, A. Zanut, S. Petralia, G. Valenti, F. Paolucci, L. Prodi, S. Conoci,…
10 May 2022
News on ECLIPSE project published on Unibo Magazine
Unibo Magazine talks about the ECLIPSE project in the article “With ECLIPSE, rapid, reliable…